| 发明名称 |
ANHYDROUS ALENDRONATE MONOSODIUM SALT FORMULATIONS |
| 摘要 |
Disclosed is a method for treating and preventing bone loss in patients by administering a formulation of anhydrous alendronate sodium. Also described is a pharmaceutical dosage form of said anhydrous alendronate sodium, being anhydrous 4-amino-1-hydroxy-butylidene-1,1-bisphosphonic acid, monosodium salt, in a pharmaceutically acceptable excipient.
|
| 申请公布号 |
CA2221417(A1) |
申请公布日期 |
1996.12.12 |
| 申请号 |
CA19962221417 |
申请日期 |
1996.06.03 |
| 申请人 |
MERCK & CO., INC. |
发明人 |
OSTOVIC, DRAZEN;THIES, J. ERIC;OBERHOLTZER, EARL R., JR.;BRENNER, GERALD S. |
| 分类号 |
A61K31/66;A61P19/10;A61P43/00;C07F9/38;(IPC1-7):A61K31/66 |
主分类号 |
A61K31/66 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
